İstanbul Medical Journal (Jan 2019)

Clinical Results of a Violet-light Filtering Aspheric Intraocular Lens

  • Dilek Yaşa,
  • Ali Demircan,
  • Banu Acar,
  • Merve Torun,
  • Onur Ölçücü,
  • Ufuk Ürdem,
  • Alper Ağca,
  • Ahmet Demirok

DOI
https://doi.org/10.4274/imj.galenos.2018.25993
Journal volume & issue
Vol. 20, no. 1
pp. 31 – 34

Abstract

Read online

Introduction:To evaluate the visual and refractive outcomes after implantation of a monofocal aspheric yellow chromophore intraocular lens (Eyecryl Plus ASHFY600, Biotech Vision Care Pvt. Ltd., Ahmedabad, India).Methods:Medical records of patients, who underwent cataract surgery and had intraocular lens implantation, were retrospectively analyzed. One eye of each patient was evaluated. Subjective manifest refraction and visual acuity results at 1 week and 1, 3 and 6 months, and intraoperative and postoperative complications were analyzed.Results:Forty-nine eyes (25 right and 24 left) of 49 patients (31 male and 18 female) were included in the study, At postoperative week 1, best corrected distance visual acuity (CDVA) was significantly increased and within an acceptable range. Uncorrected distance visual acuity (UDVA) and best CDVA were stabilized at the 1st month examination, and there was no significant difference in visual acuity between the 1st month and the 3rd and 6th month examinations. The best CDVA and UDVA at 6th months were 20/25 or better in 93% and 79% of patients, respectively. The spherical equivalent of the manifest refraction was within ± 1.00 D emmetropia in 96% of the patients. No complication occurred during or after surgery.Conclusion:CDVA and UDVA and postoperative refractive results were similar to non-chromophore lenses. The implantation of the Eyecryl Plus ASHFY600 intraocular lens has been evaluated as effective and safe.

Keywords